top of page

ZALAIN VAGINAL SUPPOSITORY 300 mg

Product details

Registration number: SIN11905P

Classification: Pharmacy Only

Active ingredients: SERTACONAZOLE NITRATE

Strength: 300 mg

Dosage form: SUPPOSITORY

Route: VAGINAL

Registrant: EURODRUG LABORATORIES SINGAPORE PTE. LTD.

ATC code: G01AF

HSA approval date: 29 April 2002

Manufacturer(s): Trommsdorff GmbH & Co, KG

Manufacturing country/countries: GERMANY

What are the HSA registration number and classification for ZALAIN VAGINAL SUPPOSITORY 300 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN11905P

Classification: Pharmacy Only

Source for this answer

What active ingredients and strength are recorded for ZALAIN VAGINAL SUPPOSITORY 300 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: SERTACONAZOLE NITRATE

Strength: 300 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ZALAIN VAGINAL SUPPOSITORY 300 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: SUPPOSITORY

Route: VAGINAL

Source for this answer

Who is the recorded registrant for ZALAIN VAGINAL SUPPOSITORY 300 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: EURODRUG LABORATORIES SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for ZALAIN VAGINAL SUPPOSITORY 300 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Trommsdorff GmbH & Co, KG

Manufacturing country/countries: GERMANY

Source for this answer

Where can I look up ZALAIN VAGINAL SUPPOSITORY 300 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN11905P or the exact product name ZALAIN VAGINAL SUPPOSITORY 300 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ZALAIN VAGINAL SUPPOSITORY 300 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ZALAIN VAGINAL SUPPOSITORY 300 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN11905P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page